Improved Synthesis of the Selective Rho-Kinase Inhibitor 6-Chloro-N4-{3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl}pyrimidin-2,4-diamine

被引：13

作者：

Schirok, Hartmut ^{[1
]}

Paulsen, Holger ^{[1
]}

Kroh, Walter ^{[1
]}

Chen, Gang ^{[2
]}

Gao, Ping ^{[2
]}

机构：

[1] Bayer Schering Pharma AG, Med Chem Wuppertal, D-42096 Wuppertal, Germany

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2010年 / 14卷 / 01期

关键词：

EMBRYONIC STEM-CELLS; VASCULAR SMOOTH-MUSCLE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; POTENTIAL THERAPEUTIC TARGET; ORGANIC FLUORINE-COMPOUNDS; BINDING PROTEIN RHO; POSTMARKETING SURVEILLANCE; CARDIOVASCULAR-DISEASES; MYOSIN PHOSPHATASE; ROCK INHIBITORS;

D O I：

10.1021/op900260k

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

A highly potent and selective Rho-kinase inhibitor containing a 7-azaindole moiety has been developed at Bayer Schering Pharma. Herein we disclose details of a significantly improved synthesis of the compound in 8.2% overall yield. Key aspects include cost and safety considerations and the uncommon use of a trifluoromethyl group with controllable reactivity as a masked methyl group.

引用

页码：168 / 173

页数：6

共 50 条

[1] Synthesis, Characterization, Biological, and Molecular Docking Studies of (Z)-N-Substituted-4-(Pyridin-2-yl)-6-(1H-Pyrrolo[2,3-b]Pyridin-4-yl)Pyrimidin-2-Amine
M. Arshad
M. S. Akhter
Russian Journal of Bioorganic Chemistry, 2022, 48 : 1068 - 1075
[2] Synthesis, Characterization, Biological, and Molecular Docking Studies of (Z)-N-Substituted-4-(Pyridin-2-yl)-6-(1H-Pyrrolo[2,3-b]Pyridin-4-yl)Pyrimidin-2-Amine
Arshad, M.
Akhter, M. S.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (05) : 1068 - 1075
[3] 6-chloro-N4-(2,2,6,6-tetramethylpiperidin-4-yl)-N2-(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4-diamine
Dong, Jun-Ying
Huang, Peng-Mian
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4113 - U3640
[4] PYRROLO[2,3-B]PYRIDINE DERIVATIVES (7-AZAINDOLES) .8. SYNTHESIS AND SOME REACTIONS OF 4-METHYL-1-PHENYL-1H-4-METHYL-1-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE
YAKHONTOV, LN
RUBTSOV, MV
JOURNAL OF GENERAL CHEMISTRY USSR, 1964, 34 (08): : 2626 - +
[5] 5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine Dihydrochloride Dihydrate
Kozanecka-Okupnik, Weronika
Wurst, Klaus
Neuner, Sandro
Nerdinger, Sven
Gelbrich, Thomas
MOLBANK, 2023, 2023 (02)
[6] The synthesis of 4-benzylamino-6-methyl-1H-pyrrolo[3,2-c]pyridine and 4-benzylamino-6-methyl-1H-pyrrolo[2,3-b]pyridine
Meade, EA
Beauchamp, LM
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1996, 33 (02) : 303 - 308
[7] Discovery of 4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((6-(pyridin-3-yl)-1H-pyrazolo[3,4-d] pyrimidin-4-yl)-oxy)benzamide as a potent inhibitor of RET and its gatekeeper mutant
Li, Xiaoyang
Su, Jingyi
Yang, Yanru
Lian, Wenhua
Deng, Zhou
Yang, Zaiyou
Chen, Guyue
Zhang, Baoding
Dong, Chao
Liu, Xueyan
Li, Li
Wang, Zheng
Hu, Zhiyu
Xu, Qingyan
Deng, Xianming
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
[8] L-745,870 (3-{[4(4-chloro-phenyl)piperazin-1-yl]methyl}-1H-pyrrolo[2,3-B]pyridine): A high affinity and selective dopamine D4 receptor antagonist
Patel, S
Patel, S
Marwood, R
Fletcher, AE
Kulagowski, J
Ragan, CI
Leeson, PD
Freedman, SB
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P30 - P30
[9] N-[(3RS,4RS)-1-Benzyl-4-methyl-piperidin-3-yl]-5-nitro-1-phenyl-sulfonyl-1H-pyrrolo[2,3-b]pyridine-4-amine
Pfaffenrot, Ellen
Schollmeyer, Dieter
Laufer, Stefan
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3051 - +
[10] Synthesis of 3-[[4-(4-[18F] fluorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine
Eskola, O
Bergman, J
Lehikoinen, P
Haaparanta, M
Grönroos, T
Forsback, S
Solin, O
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (08): : 687 - 696

← 1 2 3 4 5 →